Is The 510(k) Program At Odds With Regulatory Science?
This article was originally published in The Gray Sheet
Executive Summary
According to the Larry Kessler, the 510(k) pre-market clearance process is not conducive to advances in how FDA and industry understand device safety and effectiveness.